Abstract Psoriasis is treated with an infrared absorbing compound, preferably but not exclusively by occluding psoriatic lesions with a plastic film containing at least one compound which strongly absorbs infrared radiation in the range of from about 700 to about 1400 nanometers. The invention also includes a dressing for treating psoriasis incorporating one or more infrared blocking compounds. The infrared absorbing materials are preferably but not necessarily dispersed uniformly through a flexible carrier transparent to visible light, such as polyvinyl chloride (PVC) film or poly (methyl methacrylate) (PMMA) film, by known techniques of solution casting or dying. The materials can be used as the sole therapeutic agent, or as an adjunct to local and/or systemic treatments for psoriasis.
A method for treating psoriasis which comprises covering the affected area with a material containing an infrared absorbing amount of at least one infrared radiation blocking compound, said amount of said at least one blocking compound being sufficient to substantially reduce the escape of body heat via infrared radiation.
Claim 2
Independent Claim
49 words
A method for treating psoriasis which comprises covering the affected area with a material containing an infrared absorbing amount of at least one infrared radiation blocking compound, said amount of said at least one blocking compound being sufficient to substantially reduce the escape of body heat via infrared radiation.
Claim 3
Dependent Claim
11 words
The method of claim 1 wherein the material is a dressing.
Claim 4
Dependent Claim
18 words
The method of claim 1 wherein a topical antipsoriatic medication is applied to the skin being covered film.
Claim 5
Dependent Claim
15 words
The method of claim 2 wherein the dressing further comprises a medical grade adhesive compositions.
Claim 6
Dependent Claim
16 words
The method of claim 4 wherein the adhesive composition comprises a polymer, and a water-swellable hydrocolloid.
Claim 7
Dependent Claim
34 words
The method of claim 1 wherein the infrared blocking compound is present in an amount sufficient to maintain the temperature of the affected area within 1° C. of the temperature of adjacent healthy skin.